Please login to the form below

Not currently logged in
Email:
Password:

The Bloc

This page shows the latest The Bloc news and features for those working in and with pharma, biotech and healthcare.

UK government’s low-skill migration plans ‘will hit social care’

UK government’s low-skill migration plans ‘will hit social care’

the sector under strain unless it is made much more attractive to work in. ... the bloc's reduced size following Brexit.”.

Latest news

  • MHRA cut out of regulatory work as Brexit looms MHRA cut out of regulatory work as Brexit looms

    The paper also says the UK regulator – which has traditionally handled up to a third of applications across the EU bloc – is also having existing contracts taken away to be completed ... all adverse events, so the loss of its expertise is a big blow

  • AstraZeneca joins Merck in Brexit stockpiling effort AstraZeneca joins Merck in Brexit stockpiling effort

    checks and potentially other issues such as the need for duplicate product testing. ... In the meantime, there are already reports that the EU is preparing to issue a warning to EU member states to step up preparations for the UK exiting from the bloc

  • NHS bracing for 'no deal’ Brexit impact, including medicines NHS bracing for 'no deal’ Brexit impact, including medicines

    At the same time, strenuous efforts are being taken to train and recruit ‘home-grown’ doctors and nurses. ... wake of the country’s departure from the bloc on 29 March 2019.

  • Pharma demands guarantees for UK sector deal Pharma demands guarantees for UK sector deal

    Meanwhile Brexit still threatens to isolate the UK from the European Medicines Agency bloc, a move which would see it relegated in importance as a launch market. ... Among his recommendations, Nordkamp suggested the UK takes a leaf out of a neighbour’s

  • McCann Health cleans up at The Creative Floor Awards 2017 McCann Health cleans up at The Creative Floor Awards 2017

    Shaheed Peera, founder of the awards, said: “Congratulations to all our finalists and winners. ... FCB Health. AMV BBDO. The Bloc. Havas Lynx. Sanofi Genzyme Europe MS.

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Opening up market access Opening up market access

    Across Europe there are considerable challenges in clearing the ‘fourth hurdle’, with healthcare technology assessment in a number of key markets facing change and uncertainty. ... We also hear about the improvements in the Turkish market - currently

  • The doctor will see you now? The doctor will see you now?

    As can be seen, long waits can be expected in the UK, Ireland, the Nordic countries, Italy, Spain and parts of the former Eastern bloc. ... This brings up the gatekeeping issue - a kind of watershed in healthcare policy.

  • Paging Dr Millennial Paging Dr Millennial

    In the case of millennial doctors specifically, five key influences come into play:. ... Mariana Sanchez de Ovando is SVP, global executive director of Indigenus and Stephanie Berman is a partner at The Bloc, a founder member of the Indigenus health and

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Indigenus Announces the Winners of the 2015 indiGENIUS Awards

    The Bloc in New York. ... Americas: The Bloc (United States), CPC Healthcare Communications (Canada), Thanks (Brazil), Marketing Latino (Mexico); Europe: serviceplan health &life (Germany), Strategik &Numerik (France), thenewway (Italy), HealthWay (Poland

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics